Viewing Study NCT02029950


Ignite Creation Date: 2025-12-24 @ 4:55 PM
Ignite Modification Date: 2026-01-04 @ 6:02 PM
Study NCT ID: NCT02029950
Status: COMPLETED
Last Update Posted: 2020-10-14
First Post: 2014-01-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Chronic Myelomonocytic Leukemia-2 View
None High Risk Myelodysplastic Syndrome View
None Myeloproliferative Neoplasm View
Keywords: